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Introduction
Hereditary periodic fever syndromes (HPF) with their
clinical inflammation and associated symptoms impair
many aspects of affected children’s and adolescents’
lives. Patients experience fever, pain and fatigue; they
are restricted in their overall-wellbeing, functioning and
participation. Little is known about the extent of the
perceived burden of illness and its change over time.
Objectives
To study the perceived burden and treatment of the
HPF FMF, TRAPS and CAPS over 10 years.
Patients and methods
Data from patients with genetically proven FMF, TRAPS
and CAPS, who were recorded in the National Paediatric
Rheumatologic Database (NPRD) in the years from 2004
to 2013 were used for this analysis. Temporal changes in
patient-reported outcomes (e.g., overall wellbeing [NRS
0-10], pain [NRS 0-10], functional capacity [CHAQ],
school attendance) and anti-inflammatory medication
were evaluated.
Results
Altogether, 819 cases with HPF were recorded between
2004 and 2013: 703 with FMF, 47 with TRAPS and
69 with CAPS. The number of HPF patients recorded per
year increased from 98 in 2004 to 346 in 2013. Treatment
of HPF patients changed over time. While in 2004 5% of
HPF patients were on biologics, this applied to 13%
10 years later. In 2013, 2% of FMF, 22% of TRAPS and
72% of CAPS patients were treated with IL-1 blockers
and 3% of FMF, 56% of TRAPS, and 6% of CAPS patients
with TNF-blockers. On these drugs, 51% of all patients
had an active disease (physician global >0) at documenta-
tion in 2013 in comparison to 48% in 2004.
Considering the whole HPF group, patients perceived
health did not change over time. In 2013, 42% of patients
had restrictions in overall wellbeing (NRS>0) in compari-
son to 38% in 2004. However, CAPS patients reported bet-
ter health in 2013, with lower mean values for overall
wellbeing (1.35), pain (1.6) and functional limitations
(CHAQ 0.32) than in 2004 (mean values 3.25, 1.9 and
0.47, respectively). CAPS and TRAPS patients as well
reported a higher burden of illness in comparison to FMF
patients still in 2013. One in four patients of the whole
HPF group had missed school or kindergarten within the
4 weeks prior to documentation, without change over
time. However, the average number of days missed at
school decreased from 10.2 in 2004 to 5.1 in 2013.
Conclusion
HPF place a significant burden on the affected individuals.
Measures beyond drug treatment seem necessary to
ensure that patients can live a full life.
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